Exelixis
EXEL
316 hedge funds and large institutions have $4.16B invested in Exelixis in 2018 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 122 increasing their positions, 81 reducing their positions, and 45 closing their positions.
139% more call options, than puts
Call options by funds: $76.9M | Put options by funds: $32.2M
51% more repeat investments, than reductions
Existing positions increased: 122 | Existing positions reduced: 81
31% more first-time investments, than exits
New positions opened: 59 | Existing positions closed: 45
4% more funds holding
Funds holding: 303 → 316 (+13)
3.31% less ownership
Funds ownership: 82.11% → 78.79% (-3.3%)
21% less capital invested
Capital invested by funds: $5.24B → $4.16B (-$1.09B)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$39.9M |
| 2 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$33.6M |
| 3 |
Millennium Management
New York
|
+$32.4M |
| 4 |
O
OrbiMed
New York
|
+$21.9M |
| 5 |
BlackRock
New York
|
+$21.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$86M |
| 2 |
Jennison Associates
New York
|
-$68.7M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
-$68M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$50.9M |
| 5 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$48.5M |
EXEL Hedge Fund Activity: Q3 2018 in Review
316 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Exelixis (EXEL) for Q3 2018, worth a combined $4.16B — down 21% from $5.24B a quarter earlier.
Buyers outnumbered sellers: 59 funds opened new EXEL positions and 45 closed out — a net gain of 14 holders — while 122 added to existing stakes and 81 trimmed.
The largest buyer was First Trust Advisors, adding an estimated $39.9M. The largest seller was Fidelity Investments, cutting an estimated $86M.
- 316 institutional investors held Exelixis (EXEL) as of Q3 2018, up from 303 in Q2 2018.
- Funds reported $4.16B of Exelixis stock for Q3 2018, down 21% quarter-over-quarter.
- 59 funds opened new Exelixis positions in Q3 2018 and 45 closed out, a net change of +14 holders.
- The largest Exelixis buyer in Q3 2018 was First Trust Advisors, an estimated $39.9M added.
- The largest Exelixis seller in Q3 2018 was Fidelity Investments, an estimated $86M sold.
Based on aggregated 13F filings for Q3 2018.